Tip 2 Diyabetli Yetişkin Bireylerde Hurma Tüketiminin Hedonik Açlık ve İştah Hormonları Üzerine Etkilerinin İncelenmesi

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The aim of this study was to investigate the effects of date consumption on hedonic hunger and appetite hormones in individuals diagnosed with type 2 diabetes.The main questions it aims to answer are: * Does date consumption reduce hedonic hunger in individuals with type 2 diabetes? * Does persimmon consumption change Ghrelin, GLP-1 and GIP concentrations in individuals with Type 2 diabetes? * Does persimmon consumption reduce HOMA-IR and HbA1c values in individuals with Type 2 diabetes? * Does consumption of persimmon reduce LDL cholesterol, total cholesterol and triglyceride concentrations in individuals with type 2 diabetes? To see the effects of date consumption on hedonic hunger and appetite hormones, the researchers will compare individuals with type 2 diabetes who consume 3 dates daily with individuals with type 2 diabetes who do not. Participants: * Individuals in the intervention group will consume 3 (25 g) Baghdad dates (15 g CHO) daily as part of the breakfast meal, while individuals in the control group will not consume dates. * Three interviews will be conducted with patients. * A record of blood findings and questionnaires will be kept during these interviews.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Maximum Age: 50
Healthy Volunteers: f
View:

• Individuals diagnosed with Type 2 diabetes aged 19-50 years (excluding menopausal women),

• Individuals with BMI between 25-35 kg/m2,

• Individuals with a Nutritional Strength Scale score of 2.5 and above,

• Individuals who agreed not to start taking new dietary supplements or alternative therapies during the study period,

• Individuals who agree not to change their current physical activity level and diet.

Locations
Other Locations
Turkey
Erzurum City Hospital
RECRUITING
Erzurum
Contact Information
Primary
AYŞE ÇAMLİ
aysecamli1996@gmail.com
+905364254169
Time Frame
Start Date: 2024-05-14
Estimated Completion Date: 2025-03-01
Participants
Target number of participants: 64
Treatments
Experimental: INTERVENTION GROUP
No_intervention: CONTROL GROUP
Related Therapeutic Areas
Sponsors
Leads: Hacettepe University

This content was sourced from clinicaltrials.gov